| Application no. and date | 17704548.1 (espacenet) (Federated) (European Patent Register), 20170210 | | Patent/reg. no. and date | DK/EP 3413894, 20200311 | | Publication date | 20181219 | | Priority no. and date | EP 16155123, 20160210, EP 16186188, 20160829 | | EP pub. no. and date |
EP 3413894 20181219 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V48438DK00 | | Inventor | BIETH, Bruno, Novartis Pharma AG
Novartis Institutes for Biomed. Research
Postfach
4002 Basel, CH,
BURKHART, Christoph, Novartis Pharma AG
Novartis Institutes for Biomed. Research
Postfach
4002 Basel, CH,
CHRIST, Andreas, Novartis Pharma AG
Novartis Institutes for Biomed. Research
Postfach
4002 Basel, CH,
DE BUCK, Stefan, Novartis Pharma AG
Novartis Institutes for Biomed. Research
Postfach
4002 Basel, CH,
KALIS, Christoph, Novartis Pharma AG
Novartis Institutes for Biomed. Research
Postfach
4002 Basel, CH,
LINDGREN, Sam, Novartis Pharma AG
Novartis Institutes for Biomed. Research
Postfach
4002 Basel, CH | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 45/06 (2006.01) , A61P 37/00 (2006.01) | | Title | Anvendelse af inhibitorer af aktiviteten eller funktionen af PI3K til behandling af primært Sjögrens syndrom | | Int. application no. | IB2017050743 | | Int. publication no. | WO2017118965 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
